- Home
- Primary Care
- Ritlecitinib Safety in Alopecia Areata: Evidence for Sustained Use in Routine Practice

2w3 min read
Medical Article
Alopecia Areata (AA) is known to have an unpredictable disease course, and can result in chronic and extensive hair loss, often progressing to more severe types of alopecia (1). Ritlecitinib has demonstrated sustained clinical efficacy with long-term treatment use, even in patients with extensive baseline hair loss (2). The pivotal ALLEGRO phase 2b

Ritlecitinib Safety in Alopecia Areata: Evidence for Sustained Use in Routine Practice
98 Reached
Similar Content

Woman presented with Fever of Unknown Origin
7717 Reached93 Comments19 Likes

How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes

Rubella Syndrome in Neonate
1396 Reached12 Comments9 Likes

Black Lesion in Old Female
1970 Reached5 Comments11 Likes

Chronic Hyperplastic Candidiasis Of The Oral Mucosa
857 Reached9 Comments11 Likes